¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"drug"¿¡ ´ëÇÑ Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú :
5
ÆäÀÌÁö:
6
ÄÚµå
¿µ¹®
ÇѱÛ
M80.4
Drug-induced osteoporosis with patho- logical fracture
º´Àû °ñÀýÀ» µ¿¹ÝÇÑ ¾à¹° À¯¹ß¼º °ñ´Ù°øÁõ
L10.5
Drug-induced pemphigus
¾à¹°À¯¹ß¼º õÆ÷â
G62.0
Drug-induced polyneuropathy
¾à¹°À¯¹ß¼º ´Ù¹ß ½Å°æº´Áõ
M32.0
Drug-induced systemic lupus erythematosus
¾à¹° À¯¹ß¼º Àü½Å È«¹Ý¼º ·çǪ½º
E06.4
Drug-induced thyroiditis
¾à¹° À¯¹ß¼º °©»ó»ù¿°
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
6
ÄÚµå
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½